High-dose Prophylactic Gabapentin (HOPE) vs. Placebo to Prevent Opioid Use for Oral Mucositis Pain During Concurrent Chemoradiation for Head and Neck Cancer

Clinical trial NCT06992427 · RECRUITING

Trial details

NCT number: NCT06992427
Sponsor: Alliance for Clinical Trials in Oncology
Status: RECRUITING
Phase: Phase 3
Study type: INTERVENTIONAL

Head and Neck Squamous Cell Carcinoma Stage I Head and Neck Cutaneous Squamous Cell Carcinoma AJCC v8 Stage II Head and Neck Cutaneous Squamous Cell Carcinoma AJCC v8 Stage III Head and Neck Cutaneous Squamous Cell Carcinoma AJCC v8 Stage IV Head and Neck Cutaneous Squamous Cell Carcinoma AJCC v8

Start date: 2025-06-05
Primary completion: 2029-08-15
Enrollment: 228

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.